The human papillomavirus in the detection of cancer of the cervix
El papilomavirus humano en la detección del cáncer de cérvix
Show authors biography
Article visits 158 | PDF visits 164
Downloads
1. Campiomn M. Preinvasive Disease In: Berek J, Hacker N. Practical Gynecologic Oncology. Philadelphia: Lippincott, 2000.
2. Adam E, Berkova Z, Daxnerova J, Icenogle J, Reeves WC, Kaufman RH. Papillomavirus detection: Demographic and behavioral characteristics influencing the identification of cervical disease. Am J Obstet Gynecol 2000; 182(2): 257-64.
3. Cates W, and the American Social Health Association Panel. Estimates of the incidence and prevalence of sexually transmited diseases in the United States. Sex Transm Dis 1999; 26:S2-S7.
4. Boch FX, Muñoz N, Sanjosé de S, Navarro C, Moreo R. Et al. Human Papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case control study in spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993; 2:415-22.
5. Koutsky L.A, Holmes KK, Critchlow CW, Stevens C.E, Paavonen J, et al. A ohort study of the risk of cervical intraephitelial neoplasia grade 2 or 3 in relation the papillomavirus infection. N Engl J Med 1992; 327:1272-78.
6. Cubie HA, Seager AL, Beattie GJ, Monaghan S, Williams ARW. A longitudinal study if HPV detection and cervical pathology in HIV infected women. Sex Transm Infect 2000; 756:257-61.
7. International Agency for Research on Cancer. Evaluation of carcinogenic riks to humans. 1995. (IARC Monographs v.64 Human Papillomaviruses).
8. Schouten LJ, Hoppener P, Brandt van Den P, Knottnerus JA, et al. Cancer Incidence in Five Continentes. Lyon: IARC, 1992. (IARC Scientific Publication no. 120 v. 6).
9. Detección Oportuna del Cáncer del Cuello del Utero en América Latina y el Caribe. Informe Grupo de Trabajo Organización Panamericana de la Salud Nicaragua: OPS, 1996.
10. Kim JJ, Wright TC, Goldie SJ. Cost- effectivenses of alteranative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002; 287: 2382-90.
11. Koopmanschap MA, Oortmarssen van GA, Agt van HMA, Ballegooijen van M, Habbema JD, Lubbe KT. Cervical cancer screening: attendance and cost-effectivensess. Int J. Cancer 1990: 45:410-15.
12. Urquiza M, Guevara T, Espejo F, Bravo MB, Rivera Z, Patarroyo ME. Two L 1 -peptides are excellent tools for serological detection of HPV-associated cervical carcinoma lesions. BBRC 2005; 332:224-32.
13. Academia Nacional de Medicina, Bogotá. Comunicado a la opinión pública sobre el trabajo de investigación de la Fundación Instituto de Inmunología de Colombia, bajo la dirección del académico honorario doctor Manuel Elkin Patarroyo. Bogotá: 2005. 2h.
Information
Keywords
